Epoch Investment Partners’s Integra LifeSciences IART Stock Holding History

Epoch Investment Partners’s Portfolio IART Stock Details IART Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-248,112	Closed	-$9.9M	–	294
2016 Q2	$9.9M	Sell	248,112 -556,460	-69%	-$20M	0.04%	184
2016 Q1	$27.1M	Buy	804,572 +25,578	+3%	+$797K	0.1%	142
2015 Q4	$26.4M	Buy	778,994 +9,500	+1%	+$297K	0.1%	144
2015 Q3	$22.9M	Sell	769,494 -916,448	-54%	-$28.7M	0.09%	157
2015 Q2	$46.4M	Buy	1,685,942 +75,182	+5%	+$2M	0.17%	113
2015 Q1	$40.6M	Sell	1,610,760 -420,829	-21%	-$9.95M	0.15%	115
2014 Q4	$45M	Sell	2,031,589 -5,530	-0.3%	-$112K	0.16%	111
2014 Q3	$41.3M	Sell	2,037,119 -58,323	-3%	-$1.16M	0.16%	114
2014 Q2	$40.3M	Sell	2,095,442 -151,080	-7%	-$2.82M	0.16%	120
2014 Q1	$42.2M	Buy	2,246,522 +75,559	+3%	+$1.46M	0.17%	121
2013 Q4	$42.3M	Buy	2,170,963 +314,507	+17%	+$5.77M	0.18%	120
2013 Q3	$30.5M	Buy	1,856,456 +42,813	+2%	+$687K	0.14%	131
2013 Q2	$27.2M	Buy	+1,813,643	New	+$26.6M	0.14%	135

Other funds holding IART

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $3.89B AUM 16.15% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Epoch Investment Partners's IART Position: Q3 2016 in Review

Epoch Investment Partners sold out of Integra LifeSciences (IART) in Q3 2016, closing a stake of 248,112 shares — an estimated $9.9M sold.

Epoch Investment Partners first reported a position in IART in Q2 2013 and held it in 13 quarters. The position peaked at $46.4M in Q2 2015. 236 funds tracked by Wall St. Rank hold IART as of Q3 2016.

Epoch Investment Partners reported no remaining Integra LifeSciences position as of Q3 2016 after selling out during the quarter.
Epoch Investment Partners sold 248,112 Integra LifeSciences shares in Q3 2016, an estimated $9.9M.
Epoch Investment Partners first reported a position in Integra LifeSciences in Q2 2013 and held it in 13 quarters.
Epoch Investment Partners's Integra LifeSciences position peaked at $46.4M in Q2 2015.
236 funds tracked by Wall St. Rank held Integra LifeSciences as of Q3 2016.

Based on Epoch Investment Partners's 13F filing for Q3 2016, filed 10 Nov 2016.